Merck & Co., Inc. (MRK): A Bull Case Theory

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Long-Term Pick. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)'s share was trading at $85.67 as of Feb 12^th. MRK’s trailing and forward P/E were 12.71 and 9.50 respectively according to Yahoo Finance.

[caption id="attachment_1238885" align="aligncenter" width="768"] A doctor in a white coat discussing clinical trial results with a patient in an oncology practice.[/caption]

Merck's fair price estimate has been updated to $188, reflecting stronger-than-expected earnings...